Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint, M Todorović… - Vojnosanitetski …, 2020 - aseestant.ceon.rs
Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint… - VOJNOSANITETSKI …, 2020 - doiserbia.nb.rs
Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint, M Todorović… - Vojnosanitetski …, 2020 - aseestant.ceon.rs
Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

[PDF][PDF] Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint… - Часопис лекара и …, 2020 - vma.mod.gov.rs
Abstract Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint, M Todorović… - Vojnosanitetski …, 2020 - scindeks.ceon.rs
Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation.

Z Stanojković, A Antić, B Balint… - … : Military Medical & …, 2020 - search.ebscohost.com
Abstract Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

[PDF][PDF] Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint… - Часопис лекара и …, 2020 - researchgate.net
Abstract Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

[PDF][PDF] Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint… - Часопис лекара и …, 2020 - vma.mod.gov.rs
Abstract Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …

[PDF][PDF] Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation

Z Stanojković, A Antić, B Balint… - VOJNOSANITETSKI …, 2020 - doiserbia.nb.rs
Abstract Background/Aim. Despite the introduction of new oral anticoagulants (dabigatran,
rivoroxaban, apixaban), vitamin K antagonists (VKA), such as warfarin and acenocoumarol …